March 12, 2020 / 1:48 PM / 23 days ago

BRIEF-Idera Pharmaceuticals Reports Q4 Loss Per Share Of $1.76

March 12 (Reuters) - Idera Pharmaceuticals Inc:

* IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 LOSS PER SHARE $1.76

* Q4 EARNINGS PER SHARE ESTIMATE $-0.35 — REFINITIV IBES DATA

* AS OF DECEMBER 31, 2019, CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS TOTALED $42.8 MILLION

* IDERA PHARMACEUTICALS - ANTICIPATE CURRENT CASH, CASH EQUIVALENTS, & SHORT-TERM INVESTMENTS WILL FUND OPERATIONS INTO FIRST QUARTER OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below